These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16370077)

  • 1. Why life-saving drugs should be public goals.
    Kamtekar R
    Indian J Med Ethics; 2004; 1(3):77-8. PubMed ID: 16370077
    [No Abstract]   [Full Text] [Related]  

  • 2. Access to AIDS medicine: ethical considerations.
    Swartz O
    Indian J Med Ethics; 2004; 1(3):75-6. PubMed ID: 16370076
    [No Abstract]   [Full Text] [Related]  

  • 3. Priceless goods: how should life-saving drugs be priced?
    Maitland I
    Bus Ethics Q; 2002 Oct; 12(4):451-80. PubMed ID: 12708456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Access to essential drugs, human rights and global justice.
    Shalev C
    Monash Bioeth Rev; 2004 Jan; 23(1):S56-74. PubMed ID: 15835024
    [No Abstract]   [Full Text] [Related]  

  • 5. Policy watch. Profitable pills.
    Gebbie KM
    AIDS Read; 2004 Mar; 14(3):106, 109. PubMed ID: 15067998
    [No Abstract]   [Full Text] [Related]  

  • 6. Access to essential medicines: a Hobbesian social contract approach.
    Ashcroft RE
    Dev World Bioeth; 2005 May; 5(2):121-41. PubMed ID: 15842722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential Medicines in the United States--Why Access Is Diminishing.
    Alpern JD; Song J; Stauffer WM
    N Engl J Med; 2016 May; 374(20):1904-7. PubMed ID: 27192669
    [No Abstract]   [Full Text] [Related]  

  • 8. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
    't Hoen E
    Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
    [No Abstract]   [Full Text] [Related]  

  • 9. GlaxoSmithKline, Pfizer to merge HIV drug units in new company.
    AIDS Read; 2009; 19(6):206. PubMed ID: 19642236
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug prices may be too high despite WTO deal.
    Fleck F
    Bull World Health Organ; 2003; 81(10):774-5. PubMed ID: 14758442
    [No Abstract]   [Full Text] [Related]  

  • 11. Not just a tragedy: access to medications as a right under international law.
    Yamin AE
    Boston Univ Int Law J; 2003; 21(2):325-71. PubMed ID: 16514750
    [No Abstract]   [Full Text] [Related]  

  • 12. World pharmaceutical developments.
    Bale H
    World Hosp Health Serv; 2002; 38(2):1. PubMed ID: 12402745
    [No Abstract]   [Full Text] [Related]  

  • 13. Access to essential medications for HIV/AIDS in South Africa.
    Andrews S
    S Afr Med J; 2001 May; 91(5):384-7. PubMed ID: 11455797
    [No Abstract]   [Full Text] [Related]  

  • 14. Ensuring new medicines reach those in most need.
    Burrone E; Perry G
    Lancet HIV; 2015 Sep; 2(9):e362-3. PubMed ID: 26423544
    [No Abstract]   [Full Text] [Related]  

  • 15. Rights, patents, markets and the global AIDS pandemic.
    Gathii JT
    Fla J Int Law; 2002; 14(2):261-352. PubMed ID: 16526139
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug companies should cut prices for developing countries, says G8 report.
    Walgate R
    Bull World Health Organ; 2003; 81(1):72-3. PubMed ID: 12640481
    [No Abstract]   [Full Text] [Related]  

  • 17. The quality of mercy: social health insurance in the charitable liberal state.
    Folland S
    Int J Health Care Finance Econ; 2005 Mar; 5(1):23-46. PubMed ID: 15714262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developing nations and the compulsory license: maximizing access to essential medicines while minimizing investment side effects.
    Bird RC
    J Law Med Ethics; 2009; 37(2):209-21. PubMed ID: 19493067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tripping over patents: AIDS, access to treatment and the manufacturing of scarcity.
    Berger JM
    Conn J Int Law; 2002; 17(2):157-248. PubMed ID: 12688292
    [No Abstract]   [Full Text] [Related]  

  • 20. TRIPS, pharmaceuticals, developing countries, and the Doha "solution".
    Sykes AO
    Chic J Int Law; 2002; 3(1):47-68. PubMed ID: 15709299
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.